See up to 3 months of CNXU. The 7-day demo opens the 1M and 3M ranges and puts CNXU on your watchlist.
Start 7-day demoLatest CNXU insider trades
About Conexeu Sciences Inc. (CNXU)
Conexeu Sciences Inc. is an SEC registrant, filing under CIK 0002066836, classified as orthopedic, prosthetic and surgical appliances and supplies. We track it alongside the rest of the Health Care sector. Its offering priced on 11 May 2026 and it trades on NASDAQ.
CNXU Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 333,332 | $500K |
| Option exercise | 4 | 2,500,000 | |
| Other acquisition / disposition | 2 | 435,216 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CNXU insider transactions (Form 4)
2411 Form 4 filings on record, the earliest from May 15, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lynn Sebastian Purcell - Director | Open-market purchase | Common Stock | 166,666 | $3.00 footnote F1 | $500K | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Warrant | 166,666 | $0.00 footnote F2 | - | |
| ||||||
| David Robert Bogart - Officer | Option exercise | Common Stock | 750,000 | $0.00 | $750 | |
| David Robert Bogart - Officer | Option exercise | Performance Warrants | 750,000 | $0.00 footnote F3 | - | |
| ||||||
| Jeffrey Nathan Sharpe - Director | Option exercise | Common Stock | 500,000 | $0.00 | $500 | |
| Jeffrey Nathan Sharpe - Director | Option exercise | Performance Warrants | 500,000 | $0.00 footnote F2 | - | |
| ||||||
| Lynn Sebastian Purcell - Director | Other | Common Stock | 217,608 footnote F1 | $2.30 | $500K | |
| Lynn Sebastian Purcell - Director | Other | Warrant | 217,608 footnote F4 | $0.00 | $218 | |
| ||||||
| Lynn Sebastian Purcell - Director | Open-market purchase | Common Stock | 202,500 | $0.80 | $162K | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Warrant | 202,500 | $0.00 | $203 | |
| Lynn Sebastian Purcell - Director | Option exercise | Warrant | 202,500 | $0.80 | $162K | |
| Michael G. Wright - 10% Owner | Option exercise | Performance Warrants | 250,000 | $0.00 footnote F2 | - | |
| Michael G. Wright - 10% Owner | Option exercise | Common Stock | 250,000 | $0.00 | $250 | |
| ||||||
| Michael G. Wright - 10% Owner | Option exercise | Common Stock | 400,000 | $0.00 | $400 | |
| Michael G. Wright - 10% Owner | Option exercise | Performance Warrants | 400,000 | $0.00 footnote F2 | - | |
| ||||||
| Jeffrey Nathan Sharpe - Director | Option exercise | Common Stock | 500,000 | $0.00 | $500 | |
| Jeffrey Nathan Sharpe - Director | Option exercise | Performance Warrants | 500,000 | $0.00 footnote F2 | - | |
| ||||||
| Zbigniew Paul Lorenc - Director | Grant or award | Common Stock | 11,175 | $0.00 footnote F1 | - | |
| ||||||
| OnePointTwo Capital Ventures LLC - 10% Owner | Open-market purchase | Common Stock | 422,500 | $0.80 | $338K | |
| OnePointTwo Capital Ventures LLC - 10% Owner | Open-market sale | Warrant | 422,500 | $0.00 | $423 | |
| OnePointTwo Capital Ventures LLC - 10% Owner | Open-market purchase | Warrant | 422,500 | $0.00 | $423 | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Common Stock | 422,500 | $0.80 | $338K | |
| Lynn Sebastian Purcell - Director | Open-market sale | Warrant | 422,500 | $0.00 | $423 | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Warrant | 422,500 | $0.00 | $423 | |
Item 3.02, 8.01, 9.01
Item 3.02, 9.01
Item 3.02, 9.01
Item 7.01, 9.01
CNXU insider trading FAQ
What is the latest insider trade for CNXU?
Conexeu Sciences Inc. (CNXU) had 4 insider filings in the last 90 days, with the most recent on 19 October 2026. The full record for CNXU runs to 11 Form 4 filings, the earliest from 15 May 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CNXU stock?
2 insider purchases of CNXU were filed in the last 90 days, totaling $500K.
How many insiders are selling CNXU stock?
No insider sales of CNXU were filed in the last 90 days. 2 sales are on record for this company.
Where can I see CNXU SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CNXU Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lynn Sebastian Purcell view on EDGAR
- - David Robert Bogart view on EDGAR
- - Jeffrey Nathan Sharpe view on EDGAR
- - Lynn Sebastian Purcell view on EDGAR
- - Lynn Sebastian Purcell view on EDGAR
- - Michael G. Wright view on EDGAR
- - Michael G. Wright view on EDGAR
- - Jeffrey Nathan Sharpe view on EDGAR
- - Zbigniew Paul Lorenc view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where CNXU's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CNXU with a 7-day demo
- CNXU on your watchlist
- Every CNXU Form 4 filing on record
- Up to 3 months of CNXU price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
